Behavioral Medicine & Nephrology
A software platform to monitor and improve patients' adherence to medications and treatments.
Plasma Proteomic Response Signature of Children Receiving Infliximab for Crohn’s Disease
A prototype of a self-contained morcellator for preparing medication
for feeding tube delivery
A newly established link between the mechanistic role of thrombin and fibrinogen and their contribution to AD provides a novel mechanism for oral treatment.
Recent studies have linked the importance of AHR as a regulator of
EoE pathogenesis and the potential of AHR activation by small molecules as EoE therapy.
Oncostatin M biomarkers are associated with non-response to Infliximab therapy
Optimal dosing regimen for treating seizures and self-aggressive behavior
Our proprietary inhibitor binds to VAV3 thereby inhibiting the activation of RAC downstream of several oncogenes.
Stereotactic electroencephalography (SEEG)
This SEEG-based technique offers a safer, more precise method for functional brain mapping.
Perforin inhibition during vaccination can improve vaccine success
against a variety of infections and diseases for which sufficiently
efficacious immune response has proven difficult